NEK2

mutation — cross-omics
Cross-omicsMUTATION → RNACell-linePairwise association · TCGA cohorts

Across TCGA cell cohorts, NEK2 mutation is significantly associated with the RNA expression of many other genes, with 9 significant associations in total. BLOOD_Leukemia shows the largest number of these associations.

The most reproducible NEK2-associated genes across cancer lineages are IFNG, SPATA19, and WFDC12. Each is linked with NEK2 in more than 1 cancer types. Because this analysis shows association rather than direction, both NEK2-to-partner and partner-to-NEK2 results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, IFNG grouped by NEK2-low versus NEK2-high in BLOOD_Leukemia.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (NEK2→partner) and Y-score (partner→NEK2) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
BLOOD_LeukemiaIFNG →+0.233+4.152<.001.00931
BLOOD_LeukemiaSPATA19 →+0.022+5.569<.001.00131
BLOOD_LeukemiaWFDC12 →+0.244+4.874<.001.00231
BLOOD_LeukemiaOR6B3 →+0.016+4.539<.001.00731
BLOOD_LeukemiaTRIM49B →+0.158+4.874<.001.00231
BLOOD_LeukemiaTMEM244 →+0.416+4.551<.001.00431
Each partner links to its Q-omics profile. Showing the 6 strongest of 9 associations by consensus.

IFNG by NEK2 expression — BLOOD_Leukemia

Box plot of IFNG in NEK2-low vs NEK2-high samples in BLOOD_Leukemia.

Explore this box plot interactively →

Exploration